Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 10,876 | 207,834 | 0 | 0 | 0 |
| Gross Profit | 10,876 | 207,834 | N/A | N/A | N/A |
| Operating Expenses | 105,446 | 99,382 | 88,806 | 84,389 | 151,138 |
| Operating Income | -94,570 | 108,452 | -88,806 | -84,389 | -144,138 |
| Other Income | 11,297 | 10,792 | 11,315 | 12,211 | 13,826 |
| Pre-tax Income | -83,273 | 119,244 | -77,491 | -72,178 | -130,312 |
| Net Income Continuous | -83,273 | 119,244 | -77,491 | -72,178 | -130,312 |
| Net Income | $-83,273 | $119,244 | $-77,491 | $-72,178 | $-130,312 |
| EPS Basic Total Ops | -0.93 | 1.35 | -0.88 | -0.82 | -1.55 |
| EPS Basic Continuous Ops | -0.94 | 1.35 | -0.88 | -0.82 | -1.56 |
| EPS Diluted Total Ops | -0.91 | 1.33 | -0.88 | -0.82 | -1.55 |
| EPS Diluted Continuous Ops | -0.92 | 1.33 | -0.88 | -0.82 | -1.56 |
| EPS Diluted Before Non-Recurring Items | -0.94 | 1.33 | -0.88 | -0.82 | -1.49 |
| EBITDA(a) | $-94,897 | $107,500 | $-90,265 | $-87,034 | $-155,411 |